Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigenori Furukawa is active.

Publication


Featured researches published by Shigenori Furukawa.


Oncology Letters | 2014

Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer

Takafumi Watanabe; Masahiko Shibata; Hiroshi Nishiyama; Shu Soeda; Shigenori Furukawa; Kenji Gonda; Seiichi Takenoshita; Keiya Fujimori

Poor nutritional status is common in ovarian cancer. It is well known that the nutritional status of a patient with malignant disease is associated with survival, and that it can be assessed by serum levels of rapid turnover proteins (RTPs), such as retinol binding protein, prealbumin and transferrin. Systemic inflammation, usually observed in the form of elevated C-reactive protein (CRP) or neutrophil/lymphocyte ratio (NLR), occurs by various mechanisms involving numerous pro-inflammatory cytokines. These include interleukin (IL)-17 and other soluble protein mediators, such as soluble IL-2 receptor (sIL-2R) and vascular endothelial growth factor (VEGF). In this study, circulating levels of RTP were decreased in advanced stages of ovarian cancer, and significant inverse correlations were found between RTP levels and serum levels of CRP or NLR. CRP levels were also correlated with serum levels of VEGF and sIL-2R. Moreover, NLR, VEGF and sIL-2R levels, and IL-17 production, were all inversely correlated with RTP levels. These findings indicate that chronic inflammation may be associated with compromised immune function, such as an impaired T-cell response, via various inflammatory proteins, including sIL-2R, VEGF and IL-17. The key mechanisms leading to cancer cachexia, in which nutritional impairment is a major clinical issue, appear to be primarily immune reactions caused by chronic inflammation. Anti-inflammatory treatments may be effective in clinically improving various symptoms associated with these mechanisms.


Journal of Obstetrics and Gynaecology Research | 2013

Two cases of paraovarian tumor of borderline malignancy

Satoshi Suzuki; Shigenori Furukawa; Hyo Kyozuka; Takafumi Watanabe; Hidenori Takahashi; Keiya Fujimori

Paraovarian tumor of borderline malignancy is rare. Only 13 cases in Japan, including the present cases, and 40 cases overseas have been reported. We report two cases of paraovarian tumor of borderline malignancy. Case 1: A 38‐year‐old woman was found to have a right ovarian cyst. Transvaginal ultrasonography showed a unilocular cystic tumor and a solid part of 8 mm in diameter within the tumor. Malignancy could not be ruled out, therefore the laparotomy was performed. The tumor was paraovarian tumor. Intraoperative rapid histological diagnosis was made and the patient was diagnosed with a serous borderline tumor. There has been no recurrence 1 year after surgery. Case 2: A 30‐year‐old woman was found to have a right hydrosalpinx, or an ovarian cyst, with a solid part inside. Transvaginal ultrasonography showed the solid part within the tumor was 14 × 9 mm. Laparoscopic surgery was performed and we diagnosed the tumor as paraovarian cyst. Histological diagnosis was mucinous borderline tumor. There has been no recurrence 11 months after surgery.


International Journal of Surgery Case Reports | 2015

Sclerosing stromal tumor of the ovary treated with 2-incision total laparoscopic cystectomy.

Shigenori Furukawa; Kiyoshi Kanno; Manabu Kojima; Miki Ohara; Shu Soeda; Satoshi Suzuki; Takafumi Watanabe; Hiroshi Nishiyama; Tsuyoshi Honda; Keiya Fujimori

Highlights • Sclerosing stromal tumor (SST) is an extremely rare benign tumor of the ovary and preoperative diagnosis of SST is difficult as it often mimics a malignant tumor.• SST occurs in young women.• Many cases of SST were treated by abdominal oophorectomy and laparoscopic surgery is seldom performed in SST cases.• We report a case of SST of the ovary in an 18-year-old girl who was diagnosed by preoperative imaging and underwent laparoscopic cystectomy.


Anticancer Research | 2013

MCP-1 Promotes Invasion and Adhesion of Human Ovarian Cancer Cells

Shigenori Furukawa; Shu Soeda; Yuichiro Kiko; Osamu Suzuki; Yuko Hashimoto; Takafumi Watanabe; Hiroshi Nishiyama; Kazuhiro Tasaki; Hiroshi Hojo; Masafumi Abe; Keiya Fujimori


SpringerPlus | 2014

The measurement of stiffness of uterine smooth muscle tumor by elastography

Shigenori Furukawa; Shu Soeda; Takafumi Watanabe; Hiroshi Nishiyama; Keiya Fujimori


Biomedical Reports | 2013

Elevated serum levels of vascular endothelial growth factor is effective as a marker for malnutrition and inflammation in patients with ovarian cancer

Takafumi Watanabe; Masahiko Shibata; Hiroshi Nishiyama; Shu Soeda; Shigenori Furukawa; Kenji Gonda; Seiichi Takenoshita; Keiya Fujimori


Tohoku Journal of Experimental Medicine | 2012

Uterine Arteriovenous Malformation Formed in a Large Uterine Cervical Myoma

Shu Soeda; Junko Ushijima; Shigenori Furukawa; Masayuki Miyajima; Kotaro Sakuma; Takafumi Watanabe; Makoto Miyazaki; Yuko Hashimoto; Hiroshi Nishiyama; Keiya Fujimori


The Journal of the Japanese Society of Clinical Cytology | 2012

Adequacy of cervical cytology by The Bethesda System cell number in specimens in cervical cancer mass screening

Yutaka Morimura; Seiko Chiba; Yukari Araki; Yoshinori Soeta; Takashi Tsukahara; Shinichi Shibata; Shigenori Furukawa; Shu Soeda; Hiroshi Nishiyama; Keiya Fujimori


日本産科婦人科學會雜誌 | 2016

ISP-11-1 The evaluation of Surgical Management for the recurrent gynecological cancer patients(Group 11 Oncology 3,International Session Poster) :

Shu Soeda; Manabu Kojima; Shinji Nomura; Shigenori Furukawa; Hiroshi Nishiyama; Takafumi Watanabe; Hidekazu Yamada; Keiya Fujimori


Fukushima journal of medical science | 2014

EFFICACY OF 2-PORT LAPAROSCOPIC SURGERY FOR GYNECOLOGIC DISEASE: INVENTION OF NEW SUTURE TECHNIQUE

Satoshi Suzuki; Shigenori Furukawa; Miki Ohara; Kiyoshi Kanno; Shun Yasuda; Takeharu Ohzeki; Takafumi Watanabe; Hidenori Takahashi; Hiroshi Suzuki; Keiya Fujimori

Collaboration


Dive into the Shigenori Furukawa's collaboration.

Top Co-Authors

Avatar

Keiya Fujimori

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Shu Soeda

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Takafumi Watanabe

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Nishiyama

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Satoshi Suzuki

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Hidenori Takahashi

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Kenji Gonda

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Kiyoshi Kanno

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Manabu Kojima

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Masahiko Shibata

Fukushima Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge